AME

Business profile & competitive position

AMETEK, Inc. is classified in the Industrials sector under the Electrical Equipment & Parts industry, but its operations sit at the intersection of precision electronics and engineered industrial components. The company runs two global operating segments: Electronic Instruments, or EIG, and Electromechanical, or EMG. EIG designs and manufactures advanced analytical, test and measurement instruments used in process, aerospace, power and industrial markets. EMG supplies precision motion control, highly engineered medical components and devices, thermal management systems, specialty metals and electrical interconnects to aerospace and defense, medical, automation and other industrial markets.

This dual-segment structure spreads revenue across instrumentation and electromechanical hardware, which by nature produces stable demand from regulated, capital-intensive end markets. The financial profile supports that interpretation: AMETEK’s net margin is 20.0% and its return on equity is 14.5%. A 20% net margin is well above what typical commodity industrial suppliers earn, pointing toward some combination of technical differentiation, pricing power and cost discipline. ROE in the mid-teens is respectable for a capital-equipment business and indicates that shareholder capital is being converted into profit at a solid clip. The company’s beta is 0.96, essentially in line with the broader market, suggesting the stock behaves with roughly market-level volatility despite its industrial end markets.

Geographic diversification is another feature of the moat. According to the latest 10-K context, in 2025 52% of EIG’s net sales and 42% of EMG’s net sales were to customers outside the United States, while the company maintained what it calls best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia. That global footprint reduces dependence on any single region and supports proximity to multinational customers.

Financial posture

AMETEK currently carries a market capitalization of $56.7 billion and trades at a trailing P/E of 36.0. Against a net margin of 20.0% and ROE of 14.5%, that multiple is best read as a quality premium rather than a deep-value valuation. Investors are paying a high price for each dollar of current earnings, which implies the market expects sustained earnings growth and continued margin resilience.

The snapshot provided does not include leverage or net-debt figures, so the posture must be judged from profitability and valuation alone. With a beta near 1, the stock is neither a low-volatility safe haven nor a high-leverage cyclical play based on the available data. The combination of a 20% net margin and a 36x P/E implies the company has already demonstrated the ability to convert revenue into profit; the open question for valuation is how much faster than industrials peers it can continue to grow.

Strategic priorities & outlook

AMETEK’s most recent 10-K frames its strategy around what it calls the AMETEK Growth Model. The stated goals are high-single-digit annual sales growth, double-digit annual EPS growth, strong cash flow generation and a superior return on total capital. These targets are pursued through a mix of organic execution and mergers-and-acquisitions discipline.

Operationally, the company emphasizes Operational Excellence: lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens, digitalization and artificial intelligence. On the growth side, it pursues strategic acquisitions with technical and cultural fit in adjacent or complementary markets aligned with secular themes. From 2021 through December 31, 2025, AMETEK completed 15 acquisitions contributing approximately $1.8 billion in annualized sales. In 2025 alone it spent $933.2 million in cash, net of cash acquired, to acquire Kern (high-precision machining and optical inspection solutions) and FARO Technologies (3D measurement and imaging solutions).

The company is also expanding in emerging markets, leveraging manufacturing footprints in China, Czechia, Malaysia, Mexico and Serbia to stay close to customers and manage costs. Financially, 2025 was a record year: AMETEK reported sales of $7,401.1 million, up 6.6% from 2024, and diluted EPS of $6.40, up 7.9%. It also achieved record operating income, net income, orders and backlog, and employed approximately 22,500 people as of December 31, 2025.

Macro & geopolitical exposure

As an Electrical Equipment & Parts company with significant aerospace, defense, medical, power, process and automation exposure, AMETEK sits in the middle of several macro and geopolitical crosscurrents. Demand is linked to industrial capital expenditure cycles, aerospace build rates, defense budgets, healthcare spending and factory automation trends. When those broad categories slow, orders for test instruments, motion control and specialty components can soften; when they expand, backlog and shipments tend to improve.

Because a large share of sales—52% of EIG and 42% of EMG—goes outside the United States, the company is exposed to currency translation, cross-border trade policy and tariffs. Its manufacturing presence in China, Malaysia, Mexico and Serbia means supply-chain and logistics decisions are sensitive to geopolitical relationships and local regulatory regimes. The sector is also exposed to semiconductor and raw-material availability, environmental and export-control regulations on advanced electronics, and medical-device regulatory standards. None of these are company-specific inventions; they follow directly from AMETEK’s classification as a global electrical-equipment and electronic-instrumentation supplier.

Recent developments

The most recent news flow, as of the data snapshot dated October 19, 2026, centers on the approaching third-quarter report and institutional position changes. On October 15, 2026, AMETEK announced its third quarter 2026 earnings call and webcasted investor conference call, per PR Newswire. The same day, Zacks.com published the headline “Is AMETEK (AME) Outperforming Other Computer and Technology Stocks This Year?”—a reminder that sell-side data providers sometimes classify the stock as a technology name even though its exchange sector is Industrials.

Also on October 15, 2026, disclosure filings showed that Krilogy Financial LLC purchased shares of AMETEK, according to defenseworld.net. A few days earlier, on October 9, 2026, GAMMA Investing LLC also reported a new purchase of AME stock, per the same source. These are small advisory-level disclosures, not broad institutional flows, but they add to the pre-earnings news backdrop. The current technical snapshot as of October 19 shows AMETEK at $247.51, with an RSI of 51.1 and a 50-day EMA of $244.61. The price sits just above its 50-day moving average and the RSI is neutral.

Earnings behavior & post-earnings drift

AMETEK’s earnings history over the last eight reported quarters is one of the cleanest beat records available: 8 out of 8 beats, or 100%, with an average earnings surprise of 4%. Despite that consistency, the average 5-trading-day post-earnings move has been 0.46%, classified as “flat”. In other words, the market has generally anticipated the upside rather than rewarded it with sustained follow-through.

The four most recent reports illustrate the pattern clearly. On August 4, 2026, AMETEK reported EPS of $2.09 against an estimate of $1.99, a 5% positive surprise; the stock rose 0.28% the next day and 0.89% over the following five sessions. On April 30, 2026, EPS of $1.97 beat the $1.90 estimate by 3.7%, yet the stock fell 2.13% the next day and 0.33% over the next five days. On February 3, 2026, EPS of $2.01 beat the $1.94 estimate by 3.6%, with a next-day drop of 0.48% but a five-day gain of 1.83%. And on October 30, 2025, EPS of $1.89 beat the $1.76 estimate by 7.4%, pushing the stock up 1.91% the next day before giving back 0.54% over the following five sessions.

The takeaway from the history is not whether AMETEK will beat—it has done so in every quarter reviewed—but how the market prices that expectation. With a strong record but a near-zero average 5-day drift, subsequent earnings events may continue to be priced in ahead of the report. The next scheduled release is November 3, 2026, before the market open, with a consensus EPS estimate of $2.11.

For a deeper dive into the complete institutional verdict on AMETEK—including the latest analyst ratings, estimate revisions and ownership changes—see the full report on the platform.